Patents by Inventor Berhane Ghebrehiwet

Berhane Ghebrehiwet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR C1Q TARGETED THERAPY
    Publication number: 20190389960
    Abstract: This application provides methods for treating cancer by administering to a patient a therapeutically effective amount of an agent that binds to membrane-bound C1q. The application further provides methods for inhibiting cell proliferation comprising contacting a cell expressing membrane-bound C1q with an agent that inhibits the interaction of soluble gC1qR with the membrane-bound C1q.
    Type: Application
    Filed: June 24, 2019
    Publication date: December 26, 2019
    Inventors: Berhane Ghebrehiwet, Ellinor Peerschke
  • Methods for preventing and treating angioedema
    Patent number: 8883153
    Abstract: One aspect of the present invention provides a method of treating or preventing angioedema in a patient in need thereof comprising administering to the patient a therapeutically effective amount of an agent that is capable of inhibiting the interaction of HK with gC1q-R. One aspect of the present invention provides a method of treating or preventing vascular permeability in a patient in need thereof comprising administering to the patient a therapeutically effective amount of an agent that is capable of inhibiting the interaction of HK with gC1q-R.
    Type: Grant
    Filed: March 29, 2010
    Date of Patent: November 11, 2014
    Assignee: The Research for The State University of New York
    Inventor: Berhane Ghebrehiwet
  • METHODS FOR PREVENTING AND TREATING ANGIOEDEMA
    Publication number: 20120082676
    Abstract: One aspect of the present invention provides a method of treating or preventing angioedema in a patient in need thereof comprising administering to the patient a therapeutically effective amount of an agent that is capable of inhibiting the interaction of HK with gC1q-R. One aspect of the present invention provides a method of treating or preventing vascular permeability in a patient in need thereof comprising administering to the patient a therapeutically effective amount of an agent that is capable of inhibiting the interaction of HK with gC1q-R.
    Type: Application
    Filed: March 29, 2010
    Publication date: April 5, 2012
    Applicant: The Research Foundation of State University of New York
    Inventor: Berhane Ghebrehiwet